Literature DB >> 25720565

Successful Pregnancy in a Woman with Maple Syrup Urine Disease: Case Report.

Stefanie Heiber1, Henryk Zulewski, Marianne Zaugg, Caroline Kiss, Matthias Baumgartner.   

Abstract

We present the positive outcome of a pregnancy in a woman with severe classic maple syrup urine disease (MSUD). Maintaining the maternal plasma levels of leucine between 200 and 300 μmol/L allowed normal development of the foetus. Tolerance of protein and leucine increased continuously from the 16th gestational week until delivery. The patient was able to increase protein and leucine intake from 5 g to nearly 30 g and 300-3,000 mg/day, respectively. Weekly measurement of branched-chain amino acid (BCAA) concentrations and the assessment of dietary intake were used to adjust protein intake. After 41 weeks of pregnancy, she gave birth to a healthy baby girl and was able to breastfeed her daughter for 6 months during which time, the protein and leucine intake were lower than during pregnancy, but higher than with her usual pre-pregnancy diet. The development of the girl is normal at the age of 3 years.

Entities:  

Year:  2015        PMID: 25720565      PMCID: PMC4470944          DOI: 10.1007/8904_2014_401

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  7 in total

1.  MAPLE SYRUP URINE DISEASE, WITH PARTICULAR REFERENCE TO DIETOTHERAPY.

Authors:  S E SNYDERMAN; P M NORTON; E ROITMAN; L E HOLT
Journal:  Pediatrics       Date:  1964-10       Impact factor: 7.124

2.  A new syndrome: progressive familial infantile cerebral dysfunction associated with an unusual urinary substance.

Authors:  J H MENKES; P L HURST; J M CRAIG
Journal:  Pediatrics       Date:  1954-11       Impact factor: 7.124

3.  Impact of longitudinal plasma leucine levels on the intellectual outcome in patients with classic MSUD.

Authors:  Björn Hoffmann; Christoph Helbling; Peter Schadewaldt; Udo Wendel
Journal:  Pediatr Res       Date:  2005-12-02       Impact factor: 3.756

4.  Pregnancy in a woman with maple syrup urine disease.

Authors:  S Grünewald; F Hinrichs; U Wendel
Journal:  J Inherit Metab Dis       Date:  1998-04       Impact factor: 4.982

5.  The management of pregnancy in maple syrup urine disease: experience with two patients.

Authors:  Michel Tchan; M Westbrook; G Wilcox; R Cutler; N Smith; R Penman; B J G Strauss; B Wilcken
Journal:  JIMD Rep       Date:  2013-02-14

6.  Maple syrup urine disease: interrelations between branched-chain amino-, oxo- and hydroxyacids; implications for treatment; associations with CNS dysmyelination.

Authors:  E Treacy; C L Clow; T R Reade; D Chitayat; O A Mamer; C R Scriver
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

7.  Case reports of successful pregnancy in women with maple syrup urine disease and propionic acidemia.

Authors:  S C Van Calcar; C O Harding; S R Davidson; L A Barness; J A Wolff
Journal:  Am J Med Genet       Date:  1992-11-15
  7 in total
  3 in total

1.  Nutrient management in the intrapartum period in maternal maple syrup urine disease.

Authors:  Chika Takano; Mika Ishige; Erika Ogawa; Nobuhiko Nagano; Tamaki Morohashi; Aya Okahashi; Kaori Kawakami; Atsushi Komatsu; Kei Kawana; Tatsuhiko Urakami; Ichiro Morioka
Journal:  Mol Genet Metab Rep       Date:  2021-01-29

2.  Pregnancy in an adolescent with maple syrup urine disease: Case report.

Authors:  Michelle E Abadingo; Mary Ann R Abacan; Jeanne Ruth U Basas; Carmencita D Padilla
Journal:  Mol Genet Metab Rep       Date:  2021-03-26

Review 3.  Successful pregnancy in maple syrup urine disease: a case report and review of the literature.

Authors:  Sarah Catharina Grünert; Stefanie Rosenbaum-Fabian; Anke Schumann; Karl Otfried Schwab; Nadja Mingirulli; Ute Spiekerkoetter
Journal:  Nutr J       Date:  2018-05-12       Impact factor: 3.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.